Correlation Between Plandai Biotech and Paragon Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Plandai Biotech and Paragon Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Plandai Biotech and Paragon Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Plandai Biotech and Paragon Technologies, you can compare the effects of market volatilities on Plandai Biotech and Paragon Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Plandai Biotech with a short position of Paragon Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Plandai Biotech and Paragon Technologies.

Diversification Opportunities for Plandai Biotech and Paragon Technologies

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Plandai and Paragon is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Plandai Biotech and Paragon Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paragon Technologies and Plandai Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Plandai Biotech are associated (or correlated) with Paragon Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paragon Technologies has no effect on the direction of Plandai Biotech i.e., Plandai Biotech and Paragon Technologies go up and down completely randomly.

Pair Corralation between Plandai Biotech and Paragon Technologies

Given the investment horizon of 90 days Plandai Biotech is expected to generate 53.54 times more return on investment than Paragon Technologies. However, Plandai Biotech is 53.54 times more volatile than Paragon Technologies. It trades about 0.27 of its potential returns per unit of risk. Paragon Technologies is currently generating about 0.04 per unit of risk. If you would invest  0.01  in Plandai Biotech on December 26, 2024 and sell it today you would earn a total of  0.00  from holding Plandai Biotech or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.36%
ValuesDaily Returns

Plandai Biotech  vs.  Paragon Technologies

 Performance 
       Timeline  
Plandai Biotech 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Plandai Biotech are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Plandai Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.
Paragon Technologies 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Paragon Technologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Paragon Technologies may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Plandai Biotech and Paragon Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Plandai Biotech and Paragon Technologies

The main advantage of trading using opposite Plandai Biotech and Paragon Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Plandai Biotech position performs unexpectedly, Paragon Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paragon Technologies will offset losses from the drop in Paragon Technologies' long position.
The idea behind Plandai Biotech and Paragon Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk